Panel Q&A on Inflammation, Tau, and DIAN-TU Research

Description: A roundtable session on recent developments emerging out of DIAN-TU research, with a focus on recent discoveries about the possible role inflammation plays in the progression of Alzheimer’s disease, as well as discussion of future directions for DIAN-TU research studies
Runtime: 01:49:38

Speaker: Eric McDade, DO
Speaker title: DIAN Trials Unit Associate Director
Speaker organization: Washington University in St. Louis

Speaker: Randall Bateman, MD
Speaker title: DIAN Trials Unit Director
Speaker organization: Washington University in St. Louis

Speaker: Maria Carrillo, PhD
Speaker title: Chief Science Officer
Speaker organization: Alzheimer’s Association

Speaker: Lindsay Hohsfield, PhD
Speaker title: Assistant Project Scientist
Speaker organization: University of California, Irvine

Speaker: Michael Irizarry, MD, MPH
Speaker title: Vice President of Clinical Development for Neurology
Speaker organization: Eisai

Speaker: Cynthia Lemere, PhD
Speaker title: Associate Professor of Neurology
Speaker organization: Brigham & Women’s Hospital

Speaker: Erik Roberson, MD, PhD
Speaker title: Director, Alzheimer’s Disease Research Center
Speaker organization: University of Alabama at Birmingham

Speaker: Sheila Seleri, MD, PhD
Speaker title: Principal Medical Director – Neuroscience
Speaker organization: Genentech

Event: 2021 Virtual DIAD Family Conference: Beyond Abeta
Year: 2021

Search tags: accelerated approval, primary prevention, tau therapies, public-private partnership, inflammation, immune system, microglia, ARIA, imaging, tau tangles, hyperphosphorylation, antibodies, E2814, DIAN-TU NexGen Trials, microtubule binding region, study design, combination therapy, genetic testing, genetic status, continuity of care, research participation, open-label extension, expanded access programs, patient assistance programs, IVF, fertility, family planning